000 | 01831 a2200505 4500 | ||
---|---|---|---|
005 | 20250514170846.0 | ||
264 | 0 | _c20040303 | |
008 | 200403s 0 0 eng d | ||
022 | _a0004-0010 | ||
024 | 7 |
_a10.1001/archsurg.139.2.142 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHijjawi, John | |
245 | 0 | 0 |
_aPlatelet-derived growth factor B, but not fibroblast growth factor 2, plasmid DNA improves survival of ischemic myocutaneous flaps. _h[electronic resource] |
260 |
_bArchives of surgery (Chicago, Ill. : 1960) _cFeb 2004 |
||
300 |
_a142-7 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDNA |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIschemia _xprevention & control |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPlasmids _xpharmacology |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-sis _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRectus Abdominis _xpathology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aSurgical Flaps _xblood supply |
700 | 1 | _aMogford, Jon E | |
700 | 1 | _aChandler, Lois A | |
700 | 1 | _aCross, Kevin J | |
700 | 1 | _aSaid, Hakim | |
700 | 1 | _aSosnowski, Barbara A | |
700 | 1 | _aMustoe, Thomas A | |
773 | 0 |
_tArchives of surgery (Chicago, Ill. : 1960) _gvol. 139 _gno. 2 _gp. 142-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archsurg.139.2.142 _zAvailable from publisher's website |
999 |
_c14492942 _d14492942 |